Clinical Trials Sponsored by Mylin A. Torres, MD

Total 2 results

Mylin A. Torres, MD
Pfizer; Genentech, Inc.; Emory University

Terminated

A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer (TARA)

Breast Cancer | Triple Negative Breast Cancer

United States
Evandro Chagas National Institute of Infectious...
Valdiléa Veloso dos Santos, Ph.D.; Beatriz Grinzstejn, MD, PhD; Brenda Hoagland... and other collaborators

Completed

Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study (Seroincidence)

HIV Infections | Risk Behavior | HIV Seropositivity | Risk Reduction | STD | HIV Infection Primary | Risky Health Behavior

Brazil

3

Subscribe